ArticleScientific reports2025

Development of a prognostic multiomic biomarker of progression-free survival in advanced non-small cell lung cancer patients treated with first line immunotherapy.

Apurva Singh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.